Analyst Ratings for Magenta Therapeutics (MGTA)

MGTA Rating Summary

  |   Expand Research on MGTA
Overall Rating: BUY   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 5 / 10   Percentile Rank: 52%
Date Firm Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
2/28/2023 H.C. Wainwright Edward White New Coverage Buy
(N/A)		 N/A
(N/A)		 0.81
(0.70)		 -13.58% Details
1/26/2023 BTIG Yun Zhong Downgrade Neutral
(Buy)		 N/A
(N/A)		 0.50
(0.70)		 40% Details